1. Home
  2. PRSO vs BNGO Comparison

PRSO vs BNGO Comparison

Compare PRSO & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$0.76

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.12

Market Cap

12.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSO
BNGO
Founded
2008
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
12.9M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
PRSO
BNGO
Price
$0.76
$1.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$3.00
$7.00
AVG Volume (30 Days)
403.7K
130.5K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
81.23
94.50
EPS
N/A
N/A
Revenue
$14,573,000.00
$12,000,735.00
Revenue This Year
$18.48
$14.99
Revenue Next Year
$53.57
$34.73
P/E Ratio
N/A
N/A
Revenue Growth
5.99
26.26
52 Week Low
$0.73
$1.06
52 Week High
$2.37
$5.50

Technical Indicators

Market Signals
Indicator
PRSO
BNGO
Relative Strength Index (RSI) 41.56 43.69
Support Level N/A $1.08
Resistance Level $0.94 $1.19
Average True Range (ATR) 0.05 0.04
MACD 0.00 -0.00
Stochastic Oscillator 20.49 7.89

Price Performance

Historical Comparison
PRSO
BNGO

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: